Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval ahead of AUA congress would spark

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jan 19, 2023 11:25pm

275 Views

Post# 35234797

RE:RE:RE:RE:RE:RE:Accelerated Approval ahead of AUA congress would spark

Hi Rumple - Roswell Park is already treating 3 types of skin cancer with pdt off-label - basal cell carcinoma, (the most common form of skin cancer), Bowen's disease, and Nevoid basal cell carcinoma syndrome. Since these cancers are already being treated with off-label photosenstizers, once TLD1433 is approved for NMIBC, maybe they could use TLD1433 instead.

Rumpl3StiltSkin Wrote:

Thanks Eoga,

Very interesting. Skin Cancers, in total, look like a promising area for TLT. And a Giant market.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages